InvestorsHub Logo

vikingzskillz

09/05/17 11:27 PM

#2653275 RE: Nilbud #2652363

Huge patent allowance!! News Alert!
$EPGL wins USPTO allowance for its Piezoelectric Energy Harvesting in contact lenses. Official today. More to come. #EyePower

Hitman1127

10/23/17 7:44 PM

#2693809 RE: Nilbud #2652363

AMFIL Technologies Inc. Announces Fiscal Q1 2018 Revenues up 20,619% Year Over Year to $5,900,346 Setting A New Quarterly Financial Record For The Company

Oct 22, 2017

OTC Disclosure & News Service

Toronto, ONT, Canada -

Amfil Technologies Inc. (OTC Pink: AMFE) is pleased to provide our shareholders with a summary of our Fiscal Q1 2018 Financials and provide an update on Fiscal Q2 2018 progress thus far.

Amfil Technologies Inc. posted revenues of $5,900,374 for our Fiscal Q1 2018 up 20,619% from Fiscal Q1 2017 which posted $28,477 in total revenue. The company saw a gross profit of $1,041,121 and a net income of $114,106. The company as at FY Q1 2018 being September 30th 2017 had $297,748 in cash, $4,286,000 in inventory and $6,734,935 in total assets. As of today, the Public Float held with DTC is 285,504,206. Common Shares Outstanding is 488,797,586 and the Authorized Share Count has been reduced down to 600,000,000 from 900,000,000.

The company has been heavily reinvesting profits to fuel its expansion since Fiscal 2017. The significant profit increases posted in our recent Q1 2018 financials are a direct result of reinvesting profits to aggressively expand the Snakes & Lattes distribution business last year.

The company continued to reinvest profits into the expansion of operations through Q1 2018. Staff training, construction, administrative, and general expenses have been increased due to the upcoming opening of the new Midtown Snakes & Lattes location. This has resulted in the net income being temporarily suppressed, yet still profitable as we position the company for increased revenues and profitability moving forward. The increased staff training costs, and a large portion of the general and administrative costs will be optimized once the Midtown location begins generating revenues, which is expected in the coming weeks, resulting in increased profitability and net income.

The Fiscal Q1 2018 revenues have made a powerful statement. The revenue and gross profit numbers truly confirm the effectiveness and sustainability of the companys growth strategy. The company remains on a clear upwards trajectory with increasing momentum in terms of revenues, profits, expansion, and diversification of revenue streams. The company continues to post quarter over quarter growth, which have now almost paralleled revenues of our most recent entire Fiscal Year End. Combined with the aggressive expansion of all business divisions, the company has positioned itself for continued growth and increased profitability throughout Fiscal 2018 and into the foreseeable future.


Highlights from Fiscal Q1 2018

Purchase Order Commitment for the GRO3 and Roto-Gro Units valued at an estimated $1.15 Million for 40,000 sq ft cultivation project.Purchase Order commitment for GRO3 and Roto-Gro units for a developing 14,000 sq ft cultivation facility. Value of order is estimated at $2.5Million.Announced the Franchising of Snakes & Lattes Inc. Released the map of available franchise locations and target locations for corporate expansion.Sold first 2 franchise locations Hamilton and Kitchener/Waterloo OntarioCompleted 300M Authorized Share Count ReductionOpened hundreds of new accounts for the distribution division. Distribution sales continue to surge.Received Signing Bonus of $200,000 and First Exclusive Publishing & Distribution ContractAnnounced the recruitment of successful Hollywood graphic designer, We Engaged for Graphic Design of game art for the Snakes & Lattes publishing division.Ben Castanie Added to Board of Directors


The overwhelming support from the local community, business partners, and the investment community has defined our progress, and continues to fuel the company as it propels itself into new markets and business activities. We would like to take this time to once again thank those who have supported us through the companys progress and again reaffirm our commitment to continue the growth, expansion, and delivery of value back to our shareholders.

Stay tuned for a number of significant updates over the coming weeks as we accelerate into 2018. Key developments in the near future will include;

The franchising and expansion of the Snakes & Lattes subsidiaryGrand Opening of Snakes & Lattes Midtown locationThe cultivation facility projects being supplied by the GRO3 teamAudit completion and uplist to OTCQB/OTCQXThe spinoff of the Interloc-Kings Inc subsidiary into a separate public entity in which current shareholders will receive share dividend.Multiple strategic acquisitions


For more information regarding the company please visit www.amfiltech.comand follow us on twitter for further updates from the company @AmfilTech

For more information on Snakes & Lattes Inc. please visit www.snakesandlattes.com


For more information on GRO3, please visit gro3systems.com


Murdoc

05/29/18 12:50 PM

#2781635 RE: Nilbud #2652363

$PETV PUSH COMING >> IMHO CHECK THIS OUT


19,189,748 OS a/o 4/30/18

1,355,182 Float a/o 4/30/18

Virtually an UNKNOWN stock. No posts in the ihub board in 3 months! Easy to see that changing soon.. see the DD below, this deserves more attention imo and already getting it.. buzz picking up in case nobody has noticed. check twitter..

As of May 17th PR, PETV is bringing in their first recorded sales of any kind. Huge milestone... the float is only 1,355,182 this could have a whacky run... could test $5 - $10 easily short term imho.. I anticipate an update on how exactly the sales are going thus far to come short term.

"The sales force is commencing sales efforts in the form of a soft rollout covering eleven states."

"The Kush™ System has been produced, packaged and is ready to ship from its production facility and production partner Elite Solutions,

in Rochester, Minnesota. Several notable veterinarians that have been involved with the Kush™ System have been waiting months to order. The day has finally come that an extended treatment for Osteoarthrosis for Canine and Equine is available.The company is expecting immediate sales.

PETV believes its Kush System can become a common treatment for pets.

They are preparing to attend and present at a series of trade shows and veterinarian conferences.

Marketing and educational materials are being prepared. So far all signs point to their product being well received.

Think about all the deals they could bring in through these shows/conferences in the coming months..

All new website should be up in early June:

"Educational material will appear in a couple of weeks on the website which has a major facelift underway.

The unveiling of the site should be in 2-3 weeks."

May 17th PR
>>> https://www.otcmarkets.com/stock/PETV/news/story?e...

link to research report, goes over how Kush System works and shows a pps target of $3 (Conservative imo)
>>> http://marblearchusa.com/.../2018/05/PETV-5.1.18-2.pdf

ON THE SUBJECT OF DILUTION:
As of 12/31/17 they had one convertible note outstanding for $105k which could very well be done with now meaning no dilution to worry about..

CASH ON HAND
a/o 12/31/17 they have $557k in cash..


Link to latest Q report: https://backend.otcmarkets.com/.../12706882/content/html

10K filing due end of June

It is ironic that the name of their treatment is Kush but it has nothing to do with the cannabis plant.. Perhaps it is a hint..

Rumor going around that they will announce a cbd product for pets very soon.

Looking at weekly chart I like how it's basing on top of the cloud and seems ready to move higher again.


Ecomike

12/20/19 10:25 AM

#2796244 RE: Nilbud #2652363

I found some more Goodies to share!!! Perfect time to load $MILV and $SNPW and $QTMM $BWMG right now.

All real companies, real tech, real businesses, that are way undervalued today, with major catalysts on Tap....

$MILV R/M into a biotech with cutting edge Nano-Liposome oral drug and health supplement delivery tech that pass the Blood Brain Barrier and repair brain trauma damage. Patents, Univ of PennMed Center with 1031 patent applications in the USA alone, a guy with 131 issued patents that is a major Shareholder, and 7 shareholders with more money that they know what to do with taking it public!!!

$SNPW scored a >10 Mil dollars in a State of RI-revenue bond to help pay for a 20 Mil dollar MedicalWaste to Energy state of the art plant being assembled at the plant site right now. Operating firm with several divisions, and all Conv debt already paid that you can buy at 75% off of the 12 week highs!! And they just received an issued patent on a new solar cell design $$$$$$

$QTMM Quantum Dots, Bayer Reactor design patent bought 3 years ago, and now just bought a block chain software firm. The combination is allowing them to bring a solution to market than make counterfieting anything impossible. And thus it can tackle a 1.4 Trillion dollar per year counterfeit problem in RxDrugs, electronics, shoes, raw material like synthetic oil in Ship bulk load quantities, and on and on!!!

$BWMG a 20 year old, operating diving gear firm is starting to mass produce, and already sold and field tested a low cost, light weight diving rig that could blow up world wide sales next year, rally the stock price 25X.

Ecomike

12/26/19 12:14 PM

#2796287 RE: Nilbud #2652363

Last Biotech birth I played like $MILV was on Cramer's buy list 6 years ago at $18, a stock I loaded in 2010 at .001

I found another!!!!

$MILV is the R/M ticker and we know what is coming...

I think the last of the $MILV 3s may be gone any minute.

One of many reasons is the awesome DD like one of the major shareholders, who holds 131 issued patents in the biotech field of Lioposomes

Was part of "The Liposome Company" that ended up being acquired for $575 Million by Elan in 2000.


https://www.thepharmaletter.com/article/elan-to-acquire-the-liposome-company

What is unique about this is that the patents utilized for this company were majority of Michael W. Fountains work. This company was acquired back in 2000.

These are much older patents that do not entertain the 15-100 nm "small" or "micro" liposome technology that can pass through the BBB - Blood Brain Barrier.

Subsequently, Elan Corp gets acquired by Perrigo in 2013 for an estimate of $8.6 Billion. Obviously, Elan isn't just made up of Liposome technology.

https://investor.perrigo.com/2013-12-18-Perrigo-Company-plc-Completes-Acquisition-of-Elan-Corporation-plc

So, what I am trying to tell people here is that...... THIS IS A GOLD MINE.

We have new patents that allow researchers to take their uniquely developed compounds and insert them into Michael W. Fountains liposome technology, and carry them through the blood brain barrier and onto their target destination (explanation gets more nitty gritty).

Just an $MILV reminder folks. The loading zone in the .003x zone may close at any time.

Way undervalued, with solid bid support, as the weak hands get cleared out.

290 Mil share float. No debt. No new shares and!!!!